Comprehensive metabolomic study of platelets reveals the expression of discrete metabolic phenotypes during storage

Transfusion

Volumn 54, Issue 11, 2014, Pages 2911-2923

  Paglia, Giuseppe ^a   Sigurjõnsson, Ólafur E ^b,c   Rolfsson, Óttar ^a   Valgeirsdottir, Soley ^a   Hansen, Morten Bagge ^d   Brynjõlfsson, Sigurur ^a   Gudmundsson, Sveinn ^b   Palsson, Bernhard O ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c REYKJAVIK UNIVERSITY   (Iceland)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TRICARBOXYLIC ACID; GLUTATHIONE;

APHERESIS; ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CELL METABOLISM; CITRIC ACID CYCLE; DOWN REGULATION; GLUTATHIONE METABOLISM; GLYCOLYSIS; HUMAN; METABOLOMICS; PENTOSE PHOSPHATE CYCLE; PHENOTYPE; PURINE METABOLISM; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; THROMBOCYTE; THROMBOCYTE METABOLISM; THROMBOCYTE PRESERVATION; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; BLOOD STORAGE; CLINICAL TRIAL; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; METABOLOME; TIME;

BLOOD PLATELETS; BLOOD PRESERVATION; CITRIC ACID CYCLE; FEMALE; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; MALE; METABOLOME; METABOLOMICS; PENTOSE PHOSPHATE PATHWAY; TIME FACTORS;

EID: 84912534464     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12710     Document Type: Article

References (53)

1. Michelson AD,. Platelets. San Diego (CA): Academic Press; 2002.
2. Hogman CF,. Storage of blood components. Curr Opin Hematol 1999; 6: 427-431.
3. Vasconcelos E, Figueiredo AC, Seghatchian J,. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis. Transfus Apher Sci 2003; 29: 13-16.
4. Dijkstra-Tiekstra MJ, Pietersz RN, Hendriks EC, et al. In vivo PLT increments after transfusions of WBC-reduced PLT concentrates stored for up to 7 days. Transfusion 2004; 44: 330-336.
5. Hess JR,. Red cell changes during storage. Transfus Apher Sci 2010; 43: 51-59.
6. Bashir S, Cookson P, Wiltshire M, et al. Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets. Transfusion 2013; 53: 990-1000.
7. Goodnough LT, Shander A, Brecher ME,. Transfusion medicine: looking to the future. Lancet 2003; 361: 161-169.
8. Shrivastava M,. The platelet storage lesion. Transfus Apher Sci 2009; 41: 105-113.
9. Kocazeybek B, Arabaci U, Akdur H, et al. Prospective evaluation of platelets prepared by single and random methods during 5 days of storage: aspects related to quality and quantity. Transfus Apher Sci 2002; 26: 29-34.
10. Akay OM, Gunduz E, Basyigit H, et al. Platelet function testing during 5-day storage of single and random donor plateletpheresis. Transfus Apher Sci 2007; 36: 285-289.
11. Holme S,. Storage and quality assessment of platelets. Vox Sang 1998; 74 (Suppl 2): 207-216.
12. Gyongyossy-Issa MI,. Glucose in platelet additive solutions: to add or not to add? Transfus Apher Sci 2011; 44: 283-295.
13. Gulliksson H,. Defining the optimal storage conditions for the long-term storage of platelets. Transfus Med Rev 2003; 17: 209-215.
14. Heuft HG, Goudeva L, Krauter J, et al. Effects of platelet concentrate storage time reduction in patients after blood stem cell transplantation. Vox Sang 2013; 105: 18-27.
15. Thiele T, Iuga C, Janetzky S, et al. Early storage lesions in apheresis platelets are induced by the activation of the integrin alphaIIbbeta(3) and focal adhesion signaling pathways. J Proteomics 2012; 76 Spec No.: 297-315.
16. Paglia G, Palsson BO, Sigurjonsson OE,. Systems biology of stored blood cells: can it help to extend the expiration date? J Proteomics 2012; 76 Spec No.: 163-167.
17. Gevi F, D'Alessandro A, Rinalducci S, et al. Alterations of red blood cell metabolome during cold liquid storage of erythrocyte concentrates in CPD-SAGM. J Proteomics 2012; 76 Spec No.: 168-180.
18. Pienimaeki-Roemer A, Ruebsaamen K, Boettcher A, et al. Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles. Transfusion 2013; 53: 612-626.
19. Antonelou MH, Tzounakas VL, Velentzas AD, et al. Effects of pre-storage leukoreduction on stored red blood cells signaling: a time-course evaluation from shape to proteome. J Proteomics 2012; 76 Spec No.: 220-238.
20. Parguina AF, Garcia A,. Platelet proteomics in transfusion medicine: a reality with a challenging but promising future. Blood Transfus 2012; 10 (Suppl 2): s113-114.
21. Zolla L, D'Alessandro A,. Shaking hands with the future through omics application in transfusion medicine and clinical biochemistry. Blood Transfus 2012; 10 (Suppl 2): s1-3.
22. Schubert P, Devine DV,. De novo protein synthesis in mature platelets: a consideration for transfusion medicine. Vox Sang 2010; 99: 112-122.
23. D'Alessandro A, Gevi F, Zolla L,. Red blood cell metabolism under prolonged anaerobic storage. Mol Biosyst 2013; 9: 1196-1209.
24. Refaai MA, Phipps RP, Spinelli SL, et al. Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res 2011; 127: 287-291.
25. Holmes E, Loo RL, Stamler J, et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 2008; 453: 396-400.
26. Illig T, Gieger C, Zhai G, et al. A genome-wide perspective of genetic variation in human metabolism. Nat Genet 2010; 42: 137-141.
27. Fiehn O,. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks. Comp Funct Genomics 2001; 2: 155-168.
28. Paglia G, Magnusdottir M, Thorlacius S, et al. Intracellular metabolite profiling of platelets: evaluation of extraction processes and chromatographic strategies. J Chromatogr B Analyt Technol Biomed Life Sci 2012; 898: 111-120.
29. Paglia G, Hrafnsdottir S, Magnusdottir M, et al. Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS). Anal Bioanal Chem 2012; 402: 1183-1198.
30. Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0-The Human Metabolome Database in 2013. Nucleic Acids Res 2013; 41 (Database issue): D801-807.
31. Smith CA, O'Maille G, Want EJ, et al. METLIN: a metabolite mass spectral database. Ther Drug Monit 2005; 27: 747-751.
32. Xia J, Mandal R, Sinelnikov IV, et al. MetaboAnalyst 2.0-a comprehensive server for metabolomic data analysis. Nucleic Acids Res 2012; 40 (Web Server issue): W127-133.
33. Reich M, Liefeld T, Gould J, et al. GenePattern 2.0. Nat Genet 2006; 38: 500-501.
34. Ostrowski SR, Bochsen L, Salado-Jimena JA, et al. In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2010; 50: 2210-2219.
35. Yockey C, Murphy S, Eggers L, et al. Evaluation of the Amicus Separator in the collection of apheresis platelets. Transfusion 1998; 38: 848-854.
36. Singh H, Chaudhary R, Ray V,. Platelet indices as quality markers of platelet concentrates during storage. Clin Lab Haematol 2003; 25: 307-310.
37. Macher S, Sipurzynski-Budrass S, Rosskopf K, et al. Function and activation state of platelets in vitro depend on apheresis modality. Vox Sang 2010; 99: 332-340.
38. Hagberg IA, Akkok CA, Lyberg T, et al. Apheresis-induced platelet activation:comparison of three types of cell separators. Transfusion 2000; 40: 182-192.
39. Schwertz H, Koster S, Kahr WH, et al. Anucleate platelets generate progeny. Blood 2010; 115: 3801-3809.
40. Trygg J, Holmes E, Lundstedt T,. Chemometrics in metabonomics. J Proteome Res 2007; 6: 469-479.
41. Edward JJ,. A user's guide to principal components. New York: John Wiley & Sons; 1991.
42. Niu X, Arthur P, Abas L, et al. Carbohydrate metabolism in human platelets in a low glucose medium under aerobic conditions. Biochim Biophys Acta 1996; 1291: 97-106.
43. Guppy M, Abas L, Arthur PG, et al. The Pasteur effect in human platelets: implications for storage and metabolic control. Br J Haematol 1995; 91: 752-757.
44. Kilkson H, Holme S, Murphy S,. Platelet metabolism during storage of platelet concentrates at 22 degrees C. Blood 1984; 64: 406-414.
45. Cartledge S, Candy DJ, Hawker RJ,. Citrate metabolism by human platelets. Transfus Med 1997; 7: 211-215.
46. Baker JM, Candy DJ, Hawker RJ,. Influences of pH on human platelet metabolism. Platelets 2001; 12: 333-342.
47. Whisson ME, Nakhoul A, Howman P, et al. Quantitative study of starving platelets in a minimal medium: maintenance by acetate or plasma but not by glucose. Transfus Med 1993; 3: 103-113.
48. Saunders C, Rowe G, Wilkins K, et al. Impact of glucose and acetate on the characteristics of the platelet storage lesion in platelets suspended in additive solutions with minimal plasma. Vox Sang 2013; 105: 1-10.
49. King A, Selak MA, Gottlieb E,. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 2006; 25: 4675-4682.
50. Diab YA, Thomas A, Luban NL, et al. Acquired cytochrome C oxidase impairment in apheresis platelets during storage: a possible mechanism for depletion of metabolic adenosine triphosphate. Transfusion 2012; 52: 1024-1030.
51. Nishino T, Yachie-Kinoshita A, Hirayama A, et al. Dynamic simulation and metabolome analysis of long-term erythrocyte storage in adenine-guanosine solution. PloS One 2013; 8: e71060.
52. Crabtree HG,. Observations on the carbohydrate metabolism of tumours. Biochem J 1929; 23: 536-545.
53. Zhang L, Urtz N, Gaertner F, et al. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). Blood 2013; 122: 791-802.